Crystalys Therapeutics clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   Dotinurad Versus Allopurinol · Gout

   Trial sites expanded: 109 → 115 locations

   Crystalys Therapeutics·Phase 3· NCT07089875· Registry history of NCT07089875 on ClinicalTrials.gov (opens the registry)

   Updated Sep 28, 2026

2. Minor

   Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase…Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants

   Trial sites expanded: 38 → 41 locations

   Crystalys Therapeutics·Phase 2· NCT07535034· Registry history of NCT07535034 on ClinicalTrials.gov (opens the registry)

   Updated Sep 28, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.